Integrated analysis underlines etanercept efficacy in psoriasis

Guttman, Cheryl
May 2004
Dermatology Times;May2004, Vol. 25 Issue 5, p48
Trade Publication
Presents results of a multistudy analysis on the efficacy of subcutaneous etanercept for reducing rapid and sustained improvement in patients with chronic plaque psoriasis during the annual meeting of the American Academy of Dermatology in the U.S. Benefits of the drug; Treatment of psoriatic arthritis; Average duration of psoriasis.


Related Articles

  • Etanercept Injection Site Reaction. Clelland, Susan; Hunek, Jeffrey R. // Dermatology Nursing;Oct2005, Vol. 17 Issue 5, p375 

    This article presents the case study of a 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with the drug called etanercept. There are certain side effects of this drug. As this drug is administered through injection,...

  • Treatment of psoriasis with etanercept: An experience from South Kuwait. Al-Abdulrazzaq, Adel; Zadeh, Valid Bagher; Al-Otaibi, Sultan; Tarrab, Sahar; Najem, Nabeel // Journal of Pakistan Association of Dermatologists;2012, Vol. 22 Issue 2, p136 

    Objective To observe the efficacy and safety profile of etanercept in patients with moderate to severe plaque psoriasis. Patients and methods In this retrospective study, 56 patients were treated with etanercept between May 2005 and May 2008. All patients were screened for tuberculosis. They...

  • Long-term efficacy of etanercept for psoriasis in daily practice.  // Current Medical Literature: Dermatology;2012, Vol. 17 Issue 2, p44 

    The article presents a study on the long-term efficacy analysis of etanercept for psoraisis in daily practice. It says that 152 patients were treated with etanercept and adjustements to the dosing regimens were taken by the supervising dermatologist. Results showed that response rates were found...

  • SYMPOSIUM.  // Journal of Investigative Dermatology;Jan1992, Vol. 98 Issue 1, p44 

    The article reports that the 5th Immunoderinatology Symposium, Satellite Meeting of the 8th International Congress of Immunology will be held between 20-22 August 1992, in Szeged, Hungary. One purpose of the Symposium is to bring together inimunodermatologists from around the world to exchange...

  • ANNOUNCEMENT.  // Journal of Investigative Dermatology;Jul72, Vol. 59 Issue 1, p140 

    The Subsection of Dermatology of the Western Section of the American Federation for Clinical Research will meet as a part of the annual joint meeting of the Western Section of the American Federation for Clinical Research, the Western Society for Pediatric Research and the Western Association of...

  • PDA advances research, treatment for pigmentary disorders. Guttman, Cheryl // Dermatology Times;May2006, Vol. 27 Issue 5, p46 

    The article offers information about the third annual meeting attended by members of the Pigmentary Disorders Academy (PDA) in Hong Kong, China. The meeting focused on developing a community-based survey that investigates the natural history of melasma, a pigmentary disorder recognized as a...

  • Etanercept beats psoriasis: Biologic therapy increases quality of life for children, adolescents, as well as adults. Petrou, Ilya // Dermatology Times;May2009, Vol. 30 Issue 5, p50 

    The article discusses the therapeutic benefits of etanercept (Enbrel, Immunex) in improving the well-being of children and adolescents suffering from moderate-to-severe psoriasis. It outlines the study conducted by Doctor Amy S. Paller, professor and chairman of dermatology, at Northwestern...

  • Professional Meetings.  // Journal of Dermatologic Surgery & Oncology;Nov83, Vol. 9 Issue 11, p938 

    The article provides information on meetings to be organized by professionals in the field of dermatology, from November 1983-October 1984. Eighth M. H. Samitz Lectureship in Cutaneous Medicine will be held on November 03, 1983, led by Stephanie Jablonska, the chairman of the Department of...

  • Etanercept Effective for Moderate to Severe Psoriasis. Zepe, Bill // American Family Physician;6/1/2004, Vol. 69 Issue 11, p2675 

    Presents a study that examined the use of etanercept, a synthetic protein that binds an inflammatory signal protein, in the treatment of psoriasis. Facts about psoriasis; Prevalence of psoriasis worldwide; Side effect of the drug.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics